InvestorQ : What is the nature of Panacea agreement with Sputnik-V and how does Dr. Reddy Labs fit into the whole picture?
Dilmini Mercia made post

What is the nature of Panacea agreement with Sputnik-V and how does Dr. Reddy Labs fit into the whole picture?

Answer
image
Dawn Cherian answered.
4 months ago
Follow

Panacea Biotech has signed a licensing agreement to manufacture a total of 25 million doses of Sputnik-V. As is well known, Sputnik is the third drug granted emergency usage authorization (EUA) by the Indian authorities as an anti-COVID vaccine. Apart from Panacea Biotech and RDIF, Generium and Dr. Reddy Labs are the other signatories to this agreement. In other words, this is likely to be a four way agreement between the concerned parties.

Panacea will manufacture the Sputnik-V vaccine using "the ready to use” Generium drug substance. However, the entire quantity manufactured by Panacea will be supplied exclusively to Reddy Labs which is handling the market and distribution across India. Apart from Sputnik of Russia, the Covishield of Astra Zeneca as well as the Covaxin of Bharat Biotech have also been licensed for COVID treatment by the Indian authorities.

2 Views